Adirondack Trust Company’s Boston Scientific BSX Stock Holding History

Adirondack Trust Company’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.9K	Hold	536	–	–	0.01%	337
2026 Q1	$33.6K	Sell	536 -41	-7%	-$3.28K	0.01%	292
2025 Q4	$55K	Hold	577	–	–	0.02%	244
2025 Q3	$56.3K	Hold	577	–	–	0.02%	243
2025 Q2	$62K	Hold	577	–	–	0.02%	224
2025 Q1	$58.2K	Hold	577	–	–	0.02%	224
2024 Q4	$51.5K	Hold	577	–	–	0.02%	238
2024 Q3	$48.4K	Sell	577 -220	-28%	-$17.3K	0.02%	251
2024 Q2	$61.4K	Sell	797 -9	-1%	-$659	0.03%	221
2024 Q1	$55.2K	Buy	806 +9	+1%	+$579	0.02%	235
2023 Q4	$52.8K	Sell	797 -200	-20%	-$10.7K	0.02%	233
2023 Q3	$52.6K	Hold	997	–	–	0.03%	214
2023 Q2	$51.7K	Sell	997 -133	-12%	-$6.95K	0.02%	206
2023 Q1	$56.5K	Hold	1,130	–	–	0.03%	196
2022 Q4	$52.3K	Hold	1,130	–	–	0.03%	196
2022 Q3	$44K	Buy	1,130 +630	+126%	+$25.3K	0.02%	202
2022 Q2	$19K	Buy	+500	New	+$20.4K	0.01%	251

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Adirondack Trust Company's BSX Position: Q2 2026 in Review

Adirondack Trust Company held its Boston Scientific (BSX) position steady in Q2 2026 at 536 shares worth $22.9K. The position accounts for 0.01% of the portfolio, ranked #337.

Adirondack Trust Company first reported a position in BSX in Q2 2022 and has held it in 17 quarters since. The position peaked at $62K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Adirondack Trust Company held 536 shares of Boston Scientific worth $22.9K as of Q2 2026.
Adirondack Trust Company left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up 0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #337 holding.
Adirondack Trust Company first reported a position in Boston Scientific in Q2 2022 and has held it in 17 quarters since.
Adirondack Trust Company's Boston Scientific position peaked at $62K in Q2 2025.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.